Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders [NA]

View source ↗

Summary

A completed clinical trial compared immediate versus deferred treatment with the FW-200 Fisher Wallace Stimulator for self-reported anxiety in first responders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FW-200 Fisher Wallace Stimulator

Snippet

Sponsor: Fisher Wallace Laboratories | Conditions: Anxiety | NA | Status: COMPLETED